The Onco Life Podcast

What Is the Best Treatment for Prostate Cancer in Early Stages?

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 19:59

In this episode, we explain the best treatment options for early-stage prostate cancer and how men can make informed decisions based on their diagnosis, PSA levels, and overall health.

You’ll learn:

  •  What early-stage prostate cancer means and why early detection matters 
  •  Common signs of prostate cancer include trouble urinating and blood in the urine 
  •  The role of PSA blood tests and digital rectal exams (DRE) 
  •  The different types of prostate cancer, including adenocarcinoma and rare prostate tumors 
  •  How active surveillance helps monitor low-risk prostate cancer safely 
  •  What happens during a radical prostatectomy, and why is robotic-assisted surgery commonly used 
  •  How radiation therapy and brachytherapy work to destroy cancer cells 
  •  The benefits of focal therapies for preserving healthy tissue and reducing side effects 
  •  How doctors choose the right treatment plan based on cancer stage and patient needs 
  •  Why regular PSA tests, imaging scans, and follow-up care are important after treatment 
  •  Lifestyle tips that support recovery and long-term prostate health 

Early-stage prostate cancer is highly treatable when detected early. Understanding your treatment options can help you feel more confident about your care and improve your chances of long-term cancer control and quality of life.

Blog Link: What Is the Best Treatment for Prostate Cancer in Early Stages?

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +603-2242-2620
📧 Book a consultation or ask a question — we're here to support your journey.

SPEAKER_01

Welcome to the Onko Life Center podcast. Imagine finding out your house is on fire. You know, you call the fire department, you're in a total panic, and when they show up, they tell you, um, we're actually not going to put it out. We're just going to sit here and like watch it with a thermometer. Sounds absolutely terrifying.

SPEAKER_00

Oh, totally terrifying.

SPEAKER_01

But um when it comes to early stage prostate cancer, doing quote unquote nothing might actually be one of the most, you know, brilliant technologically advanced medical strategies available to you today.

SPEAKER_00

Aaron Powell It really is.

SPEAKER_01

Yeah. And we are so glad you could join us for today's deep dive. Because our mission is to completely demystify this exact scenario. Yeah. We're going to explore the uh quiet signs of early stage prostate cancer and basically break down the incredible myriad of modern treatment options.

SPEAKER_00

Aaron Powell It's just a vital topic. And um I want to acknowledge something straight away for anyone listening. Sure. Receiving a prostate cancer diagnosis, or, you know, even just sitting in a waiting room for the results of a routine screening, it can feel incredibly heavy.

SPEAKER_01

Oh, yeah. Completely overwhelming.

SPEAKER_00

Aaron Powell Right. It is completely normal to feel overwhelmed. But this deep dive is really designed to arm you with knowledge.

SPEAKER_01

Exactly.

SPEAKER_00

We're looking at some fantastic materials today, specifically an insightful article by Dr. Christina Neng Van Say titled, What is the best treatment for prostate cancer in early stages? Alongside um the holistic treatment models pioneered by the OncO Life Center in Kuala Lumpur, Malaysia.

SPEAKER_01

Which are just fascinating.

SPEAKER_00

They really are. And what this information proves is that early detection paired with modern personalized care leads to absolutely phenomenal life-preserving outcomes. You know, you are not without options.

SPEAKER_01

Aaron Powell Okay, let's unpack this very first step. Before you can treat a problem, you have to know it's actually there.

SPEAKER_00

Right.

SPEAKER_01

And with early stage prostate cancer, that is like famously difficult. The cancer is generally confined strictly to the prostate gland itself, and it's quiet. Trevor Burrus, Jr.

SPEAKER_00

Very quiet.

SPEAKER_01

So to help visualize why this matters, think of the prostate gland like a small um walnut-sized plumbing valve.

SPEAKER_00

Trevor Burrus, Jr. That's a good way to look at it.

SPEAKER_01

Trevor Burrus, Jr.: Yeah, wrapped right around the urethra, the tube that carries urine out of the bladder. When that valve starts acting up or enlarging, or if a tumor starts pressing against the tube, you inevitably get what we can call flow issues.

SPEAKER_00

Aaron Powell Yeah, that anatomical visual is spot on. Because of where the prostate sits, um the symptoms we see in the early stages reflect that compression.

SPEAKER_01

Makes sense.

SPEAKER_00

So you might notice trouble starting to urinate or a, you know, notably weak flow. Sometimes uh there might be blood in the urine.

SPEAKER_01

Aaron Powell, which is definitely scary.

SPEAKER_00

Absolutely. And because the prostate is nestled deep in the pelvis, nearby inflammation or tumor growth can also cause pain in the lower back, the hips, or well, the pelvis itself. Right. Unexplained weight loss is um another systemic red flag to really watch out for.

SPEAKER_01

Aaron Powell I want to pause on the medical terminology for a second because the paperwork patients get can be, I mean, it can be terrifying.

SPEAKER_00

Oh, yeah. It's like a foreign language.

SPEAKER_01

Aaron Powell Exactly. I'm seeing words like uh adenocarcinoma and focal lesions. If I'm a patient reading that on a chart, my heart is racing. Can we bring this down to an ELI five, you know, explain it like I'm five level? What do these terms actually mean?

SPEAKER_00

Let's absolutely demystify that because the fear usually comes from just not knowing the vocabulary. Right. Adenocarcinoma is a long, intimidating word, but a adeno just means gland, and carsono means cancer.

SPEAKER_01

No, okay.

SPEAKER_00

It simply means the cancer started in the gland cells, the specific cells that make up the prostate fluid. It is the most common type of prostate cancer.

SPEAKER_01

Gotcha.

SPEAKER_00

So if your doctor mentions adenocarcinoma, take a breath. It is exactly the type of cancer modern medicine is best equipped to handle.

SPEAKER_01

Okay, that is hugely reassuring. What about um focal lesions?

SPEAKER_00

A focal lesion is just a term radiologists use when they are looking at an MRI or an ultrasound.

SPEAKER_01

Like a spot on a scan.

SPEAKER_00

Exactly. It basically means a small specific spot that looks different from the surrounding tissue. It's essentially a tiny area of concern found very early on. There are also rare prostate tumors that affect other tissues, but you know, adenocarcinoma and focal lesions are really the most common terms you'll encounter in the early stages.

SPEAKER_01

But here's where I'm getting hung up.

SPEAKER_00

Okay.

SPEAKER_01

If the symptoms are so mild or practically invisible, right, like some flow issues or lower back pain, which let's face it happens to almost everyone as they get older. True. Are we just crossing our fingers and hoping men remember to ask for a blood test when they hit 50? Because that seems like a terribly fragile strategy for catching something this serious.

SPEAKER_00

This raises an important question, and you've hit on the exact reason why we don't rely on waiting for symptoms to appear.

SPEAKER_01

Right, because by then it's too late.

SPEAKER_00

Well, by the time symptoms are severe, the cancer has often advanced. This is why proactive screening is just not negotiable.

SPEAKER_01

Okay.

SPEAKER_00

For men over 50, or those with a family history of the disease, early detection relies on two simple tests, the DRE, or digital rectal exam, and crucially the PSA blood test.

SPEAKER_01

Right, PSA.

SPEAKER_00

All right, PSA stands for prostate-specific antigen.

SPEAKER_01

So how does a blood test tell us what's happening inside a you know tiny gland in the pelvis?

SPEAKER_00

Think of PSA as a specific protein produced by the prostate. Normally it stays inside the prostate ducts.

SPEAKER_01

Okay.

SPEAKER_00

But when cancer cells begin to grow, they disrupt the cellular architecture of the gland. That disruption allows the PSA protein to literally leak into the bloodstream.

SPEAKER_01

Oh, wow. So it spills out.

SPEAKER_00

Exactly. So the PSA test acts like a microscopic distress signal. Catching that signal early when it's just a whisper in the blood is the absolute cornerstone of early stage survival.

SPEAKER_01

Okay, let's unpack this. So let's say a man goes in, gets his PSA check, they do some imaging, and they find one of those focal lesions.

SPEAKER_00

An early stage adenocarcinoma here.

SPEAKER_01

Right. As we said at the top of the deep dive, the immediate human instinct is going to be total panic. Like, get this out of my body right now. But Dr. Eng's article outlines a first-line treatment option called active surveillance. And this brings us back to my house fire analogy. I am genuinely confused. Why is doing nothing a valid medical strategy when there is confirmed cancer in your body?

SPEAKER_00

What's fascinating here is that it requires a massive mental shift. I agree. We have to reframe how we think about this specific disease.

SPEAKER_01

Okay.

SPEAKER_00

Low-risk prostate cancer is rarely a raging house fire. Biologically, it is often much more like a very slow-growing weed in a garden. A weed. Yeah, a weed that might take decades to grow and might never actually spread or threaten the garden in the patient's lifetime. Huh. Active surveillance is absolutely not doing nothing. It is a highly active, rigorous, and structured protocol.

SPEAKER_01

So you're keeping the enemy under a microscope rather than like dropping a bomb on it?

SPEAKER_00

Precisely. It involves careful scheduled monitoring with regular PSA blood tests, repeat biopsies, and highly advanced imaging scans like multiparametric MRIs.

SPEAKER_01

Okay, but why not just take it out anyway, just to be safe?

SPEAKER_00

The reason this is such brilliant medical wisdom really comes down to anatomy. The prostate is nestled inside a very delicate web of nerves and blood vessels, the neurovascular bundles.

SPEAKER_01

Right.

SPEAKER_00

And those control urinary continence and sexual function. They are incredibly fragile. Any medical intervention, be it surgery or radiation, risks damaging those structures.

SPEAKER_01

Ah, I see.

SPEAKER_00

So by choosing active surveillance for low-risk cases, you entirely avoid those immediate invasive side effects. You preserve the patient's quality of life. Treatment only begins if the data shows the cancer is actually mutating or growing.

SPEAKER_01

That makes total sense. You don't use a sledgehammer on a tiny weed if you don't have to.

SPEAKER_00

Exactly.

SPEAKER_01

Especially if that weed is sitting on top of crucial nerve endings. But obviously there are times when the spans show the weed is getting aggressive.

SPEAKER_00

Right. And that pivots us from active surveillance to active eradication.

SPEAKER_01

Yeah. The materials detail two major interventions surgery and radiation. Let's start with surgery. Specifically, a uh radical prostatectomy removing the whole gland. It sounds incredibly invasive.

SPEAKER_00

The term radical sounds intimidating, definitely. But the technology used to perform this surgery has advanced light years. Today, robotic assisted surgery is the gold standard.

SPEAKER_01

Wait, clarify that for me. When you say robotic assisted, is an autonomous robot just like operating on a patient?

SPEAKER_00

No, no, not at all. The surgeon is 100% in control.

SPEAKER_01

Oh, okay. Phew.

SPEAKER_00

Yeah. The surgeon sits at a console in the operating room, looking through a high-definition 3D camera that magnifies the surgical site massively.

SPEAKER_01

Oh, wow.

SPEAKER_00

And their hand movements at the console are translated in real time to tiny, highly articulated robotic arms inside the patient.

SPEAKER_01

That's incredible.

SPEAKER_00

It is. These robotic instruments have a greater range of motion than a human wrist and completely filter out any natural hand tremors.

SPEAKER_01

Wow, so it's about superhuman precision.

SPEAKER_00

Exactly. Because they have that 3D magnification and tiny instruments, the surgeon can meticulously peel the prostate away from those fragile neurovascular bundles we talked about.

SPEAKER_01

To protect the nerve.

SPEAKER_00

Yes. By improving this microscopic precision, robotic-assisted surgery significantly reduces the risk of long-term side effects like erectile dysfunction or urine leakage.

SPEAKER_01

That's amazing.

SPEAKER_00

And the cure rate is exceptionally high. Most patients regain normal function within months.

SPEAKER_01

That is fascinating. But what if a patient doesn't want surgery or their health means they aren't a good candidate for going under anesthesia?

SPEAKER_00

Aaron Powell Then we look at radiation therapy.

SPEAKER_01

Right. And here's where it gets really interesting because the mechanics just blow my mind. You have external beam radiation, which is shooting high energy rays from outside the body.

SPEAKER_00

Correct.

SPEAKER_01

But then there is brachytherapy. Dr. Eng's article highlights this and it sounds like science fiction. You are essentially planting tiny microscopic landmines directly into the prostate.

SPEAKER_00

It really is a remarkable procedure.

SPEAKER_01

How does that physically work?

SPEAKER_00

So using ultrasound guidance to see exactly where they are going, doctors use specialized needles to implant tiny radioactive seeds. Each one is about the size of a grain of rice directly into the prostate gland itself.

SPEAKER_01

And they just like stay in there.

SPEAKER_00

Yes. They are left in place. Wow. These seeds deliver a highly localized, concentrated dose of radiation, precisely where it's needed, from the inside out.

SPEAKER_01

That's brilliant.

SPEAKER_00

Over a period of months, the radiation slowly decays and kills the cancer cell's DNA. The ultimate goal of modern eradication, whether it's external beam, brechotherapy, or robotic surgery, is a delicate balancing act.

SPEAKER_01

Right, killing the cancer without ruining everything else.

SPEAKER_00

Exactly. Maximizing the destruction of the cancer while ruthlessly protecting the nearby healthy tissues, like the bladder and the rectum. Yeah. It's also worth noting that radiation is completely non-invasive and can be combined with hormone therapy to starve the cancer cells of testosterone, which improves the overall cure rate.

SPEAKER_01

Okay, so we've talked about taking the whole prostate out or radiating the whole gland, but earlier we talked about focal lesions.

SPEAKER_00

Yes, the tiny spots.

SPEAKER_01

Right. If the MRI shows a tumor the size of a pea in just one specific corner of the prostate, taking the whole organ out feels like using a broadsword when you really only need a scalpel. Tell me there's a way to just target the pea.

SPEAKER_00

There is, and it's called focal therapy. It is exactly the scalpel or sniper approach you were describing.

SPEAKER_01

Oh, awesome.

SPEAKER_00

Why remove or radiate the entire gland if the cancer is isolated to one small quadrant?

SPEAKER_01

Right. But how do they actually do that without hitting the rest of the prostate?

SPEAKER_00

They use incredibly focused energy. Depending on the specific technology, doctors might use high-intensity focused ultrasound, literally using sound waves to heat and destroy the tissue. Wow. Or cryotherapy, which freezes the specific area. By focusing the treatment solely on the tumor itself, doctors destroy the cancer while preserving the absolute maximum amount of healthy prostate tissue.

SPEAKER_01

Which means fewer side effects.

SPEAKER_00

Drastically reduced side effects, maintaining both urinary and sexual function. It's a brilliant option for carefully selected early stage cases.

SPEAKER_01

But um, let me push back here on behalf of anyone listening who is trying to navigate this.

SPEAKER_00

Please do.

SPEAKER_01

We just laid out active surveillance, robotic surgery, external beam radiation, internal radioactive seeds, and sniper-like focal therapies.

SPEAKER_00

It's a lot.

SPEAKER_01

With all these options, if I'm sitting in a doctor's office, how do I not get completely paralyzed by choice? How on earth do you know what the best treatment is?

SPEAKER_00

That is one of the most common and really valid fears a patient experiences. And it highlights why your medical team isn't just there to hand you a menu. Right. Their role is to be your navigator and your synthesizer. Treatment is never one size fits all.

SPEAKER_01

So how do they decide?

SPEAKER_00

When an oncologist sits down with you, they are looking at a complex matrix of hard biological data. They look at your PSA velocity, the exact stage of the cancer, the Gleason score, which tells us how aggressive the tumor cells look under a microscope, and the tumor's exact location.

SPEAKER_01

So they take all that hard data, but what about the human element?

SPEAKER_00

That at the second half of the matrix. They blend the tumor data with your age, your overall baseline health, your lifestyle, and your personal risk tolerance regarding side effects.

SPEAKER_01

That's crucial.

SPEAKER_00

Very. The doctor synthesizes all this to create a tailored, safe roadmap. You and your doctor make a shared decision so you never feel like you're just throwing a dart at a board and hoping for the best.

SPEAKER_01

So what does this all mean? It means that treating the cancer is really about treating the human.

SPEAKER_00

Exactly.

SPEAKER_01

And the medical intervention, the surgery, or the radiation, is really just one chapter in this story. The rest of the book is about recovery, lifestyle, and crucially where and how you receive that care. Because stepping out of the clinic doors doesn't mean the journey is over.

SPEAKER_00

Far from it. The follow-up phase is your invisible safety net. Regular checkups are mandatory.

SPEAKER_01

Right.

SPEAKER_00

This means ongoing PSA blood tests to ensure the cancer stays undetectable, and routine MRI scans to give your doctors a clear, continuous view of the prostate bed. Long-term control requires vigilance.

SPEAKER_01

And the patient has homework too.

SPEAKER_00

Yes, they do.

SPEAKER_01

The literature emphasizes that lifestyle support is a major factor. This isn't just feel-good advice, it's biological strategy. Eating a nutrient-rich diet, exercising regularly, quitting smoking, limiting alcohol, and managing stress.

SPEAKER_00

All of that reduces systemic inflammation.

SPEAKER_01

And it gives your immune system every possible advantage to prevent a recurrence. Plus, managing the emotional toll with counseling and the physical toll with physical therapy, which brings us to the actual environment where this kind of comprehensive total body care happens.

SPEAKER_00

Yes.

SPEAKER_01

Dr. Ng's expertise brings us to the Onko Life Center, located in Wisma Life Care Level 3, in Bangzar South, Kuala Lumpur, Malaysia.

SPEAKER_00

What's deeply fascinating about Onko Life Center is looking at their patient demographics. They aren't just a local hub. Over the years, they have become a destination for patients flying in from the UK, Japan, Qatar, Germany, Iran, Bangladesh, India, Indonesia, the Philippines, Singapore, and China.

SPEAKER_01

Wow. That tells you something vital, doesn't it? When patients are looking for care that balances cutting-edge medical tech with absolute empathy and professionalism, geographical borders just completely disappear.

SPEAKER_00

They really do.

SPEAKER_01

People will travel across the globe for that specific combination.

SPEAKER_00

Exactly. It speaks to a universal need. Patients want a center whose core values, empathy, dedication, professionalism, and quality aren't just words on a wall, but are reflected in the actual infrastructure of the building.

SPEAKER_01

And speaking of infrastructure, there is one piece of technology at Onco Life Center that really caught my eye in the materials because it explains the how behind safe cancer care.

SPEAKER_00

Oh, the CDR complex.

SPEAKER_01

Yes. They have an in-house CDR complex. CDR stands for Cytotoxic Drug Reconstitution. When I first read that, I thought it sounded like a sci-fi laboratory.

SPEAKER_00

It does sound like something out of a movie.

SPEAKER_01

But when you understand what it does, it is incredibly grounded in patient safety. Can you explain why a facility needs a dedicated CDR complex?

SPEAKER_00

It's a great point because most people don't think about how cancer drugs are actually made ready for the patient. Cytotoxic drugs, which include chemotherapy and highly potent targeted therapies, are essentially designed to be toxic to rapidly dividing cancer cells. Right. That means they are incredibly dangerous to handle. You cannot just mix them on a regular pharmacy counter.

SPEAKER_01

Because if you spill a drop or if the fumes get into the air, it's a hazard.

SPEAKER_00

Precisely. The CDR complex is a highly controlled, ultra-precise, sterile environment. It utilizes specialized airflow systems and biological safety cabinets.

SPEAKER_01

Wow.

SPEAKER_00

It ensures that highly qualified pharmacy personnel can prepare the exact microdose of an oncology drug without contaminating the medicine, the surrounding environment, or themselves.

SPEAKER_01

And the materials note that this facility is certified by the National Pharmaceutical Regulatory Agency of the Ministry of Health Malaysia, which means it adheres to incredibly strict standard operating procedures.

SPEAKER_00

It's heavily regulated.

SPEAKER_01

Honestly, if you or a loved one are receiving potent cancer drugs, knowing that the physical mixing of the medication is handled with government-certified, rigorous safety protocols is deeply reassuring.

SPEAKER_00

If we connect this to the bigger picture, it illustrates the duality of modern cancer care perfectly. Real healing requires a soothing, empathetic environment where you feel heard as a human being. But it must be underpinned by uncompromising top-tier technology. Uncle Life Center's multidisciplinary approach covers everything from the initial disease assessment and genetic counseling all the way through treatment, execution, drug safety, and managing long-term side effects.

SPEAKER_01

It's comprehensive.

SPEAKER_00

Total wellness isn't just about eradicating a tumor, it's about making sure the patient feels completely safe, supported, and monitored every single step of the way.

SPEAKER_01

It really is a complete holistic ecosystem of care. We have covered so much vital ground today. We started in the dark looking at the quiet, often invisible early signs of prostate cancer, those subtle flow issues or back pains that are far too easy to brush off. We moved through the brilliant proactive science of the PSA blood test, demystified scary terms like adenocarcinoma, and ventured into a world of treatments that range from the meticulous data-driven patients of active surveillance to the high-tech precision of robotic surgery and focal therapies.

SPEAKER_00

And the absolute key takeaway for you listening to this right now is empowerment. You are now armed with a vocabulary and the understanding to advocate for your own health or the health of the men in your life.

SPEAKER_01

That's so important.

SPEAKER_00

Early stage prostate cancer is highly treatable. By combining early detection with the kind of personalized, compassionate, and technologically rigorous care we've seen at places like the Onco Life Center, the odds are overwhelmingly in the patient's favor.

SPEAKER_01

You truly do not have to navigate this in the dark anymore. The tools exist and the care exists. Absolutely. But before we wrap up today, I want to leave you with one final thought to ponder. We've talked extensively about how incredibly advanced these treatments have become and how we can target a tumor down to the millimeter. If medical technology like robotic surgery and targeted focal therapies are already preserving so much of a patient's quality of life today. Wait, let me rephrase that. If they are already preserving so much of a patient's healthy tissue today, what will the active surveillance of tomorrow look like?

SPEAKER_00

That's a great question.

SPEAKER_01

Will treating early stage cancer eventually become as routine and non invasive as a simple software update for our bodies? We hope this deep dive has given you clarity, a bit of wonder at modern medicine, and most importantly, confidence. Thank you so much for joining us, and we will catch you on the next one.